PetCure Oncology and VMCLI Fighting Pet Cancer in Long Island, NY
September 22, 2020 10:50 ET
|
PetCure Oncology
West Islip, NY, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Advanced radiation therapy for pets with cancer will soon be available in Long Island, New York following the announcement of a new collaboration...
Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conference
October 22, 2019 11:05 ET
|
PetCure Oncology
Houston, TX, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that...
PetCure Oncology Continues to Drive Radiation Therapy for Pets with 3,000th Treatment
September 26, 2019 11:45 ET
|
PetCure Oncology
Deerfield, IL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- National pet cancer care provider PetCure Oncology treated its 3,000th pet with advanced radiation therapy on Wednesday, reaching a historic...
PetCure Oncology Announces Capital Raise with Plans for Public Offering, Expansion of Pet Cancer Network
July 17, 2019 09:00 ET
|
PetCure Oncology
Deerfield, IL, July 17, 2019 (GLOBE NEWSWIRE) -- PetCure Oncology, LLC, a company providing veterinary cancer treatment utilizing non-surgical stereotactic radiosurgery (SRS) and stereotactic...
PetCure Oncology and Nanovi Announce PetXmark™ Partnership to Introduce Fiducial Guided Stereotactic Radiotherapy for Pet Patients with Cancers
December 07, 2017 10:00 ET
|
PetCure Oncology
Chicago, IL and Copenhagen, Denmark, Dec. 07, 2017 (GLOBE NEWSWIRE) -- PetCure Oncology Inc. (PetCure) and Nanovi A/S (Nanovi) announced an exclusive agreement to use PetXmark™ in the development...